Why have obesity rates soared worldwide in the last few decades? What are the promises and perils of a generation of new weight-loss drugs like Ozempic, Wegovy and Mounjaro? What treatments are in the pipeline, and will the people who need them get them? How are companies trying to shape the narrative and set themselves up to profit? What do people with obesity say about their lives?
Here you’ll find STAT’s pathbreaking coverage of obesity – one of the world’s most serious health issues and also the subject of ferocious financial competition in biotech and pharma.